Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
St. Michael's Hospital, Toronto Canadian Diabetes Association |
---|---|
Information provided by: | St. Michael's Hospital, Toronto |
ClinicalTrials.gov Identifier: | NCT00462436 |
Background: Treatment targets for cardiac risk factor reduction are not being met. Therefore, there is a need for new strategies to assist patients in meeting these goals.
Objective: To determine the amount of any additional benefit on risk factor reduction associated with the consumption of the "dietary portfolio" (a low fat diet with soy, nuts and viscous fibres), above that achieved with medical management in diabetic patients following cardiac surgery.
Description: 35 cardiac surgery patients with diabetes will be instructed on how to incorporate the dietary portfolio foods into their diet for four weeks. Changes in blood cholesterol, markers of inflammation, blood sugar control and modifiable risk factors will be assessed after 2 and 4 weeks of therapy.
Relevance: Maximizing cardiac risk factor reduction through a combined approach (dietary plus medication) should improve outcomes, reduce rates of re-hospitalization and improve quality of life in diabetic patients after heart surgery.
Condition | Intervention | Phase |
---|---|---|
Coronary Artery Disease Type II Diabetes Mellitus |
Behavioral: Consumption of Dietary Portfolio |
Phase II |
Study Type: | Interventional |
Study Design: | Prevention, Non-Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study |
Official Title: | Do Innovative Strategies Complement Medical Management to Reduce Cardiovascular Risk Factors Following Coronary Artery Bypass Graft Surgery? |
Estimated Enrollment: | 35 |
Study Start Date: | February 2007 |
Estimated Study Completion Date: | January 2009 |
Estimated Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Mary Keith, PhD, RD | 416-864-5551 | keithm@smh.toronto.on.ca |
Canada, Ontario | |
St. Michael's Hospital | Recruiting |
Toronto, Ontario, Canada, M5B 1W8 | |
Principal Investigator: Mary Keith, PhD, RD |
Principal Investigator: | Mary Keith, PhD, RD | St. Michael's Hospital, Toronto |
Responsible Party: | St. Michael's Hospital ( Dr. Mary Keith ) |
Study ID Numbers: | REB06-179C |
Study First Received: | April 17, 2007 |
Last Updated: | July 16, 2008 |
ClinicalTrials.gov Identifier: | NCT00462436 |
Health Authority: | Canada: Ethics Review Committee |
functional foods soy nuts LDL cholesterol fibre secondary prevention |
risk reduction endothelial function endothelial progenitor cells inflammation glycemic control HOMA |
Arterial Occlusive Diseases Heart Diseases Metabolic Diseases Myocardial Ischemia Diabetes Mellitus Vascular Diseases Endocrine System Diseases Ischemia Arteriosclerosis |
Inflammation Coronary Disease Diabetes Mellitus, Type 2 Neoplasm Metastasis Endocrinopathy Metabolic disorder Glucose Metabolism Disorders Coronary Artery Disease |
Cardiovascular Diseases |